CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CCRN on Nasdaq
CUSIP
227483104
Type / Class
Equity / Common Stock
Shares outstanding
32.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.7M
Holdings value
$450M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
164
Number of buys
78
Number of sells
-93
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% -13.3% $32.2M -$5.24M 2.47M -14% BlackRock, Inc. Jun 30, 2025
Magnetar Financial LLC 7.2% +19.5% $32.4M $5.26M 2.32M +19.4% Magnetar Financial LLC Dec 31, 2024
ALLIANCEBERNSTEIN L.P. 5.9% -17.1% $27.4M -$5.86M 1.93M -17.6% AllianceBernstein L.P. Sep 30, 2025
VANGUARD GROUP INC 5.67% $25.6M 1.83M The Vanguard Group Dec 31, 2024
GOLDMAN SACHS GROUP INC 3.9% -31.7% $18.1M -$8.75M 1.27M -32.6% THE GOLDMAN SACHS GROUP, INC. Sep 30, 2025

Institutional Holders of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.7M $450M +$2.88M $14.20 164
2025 Q2 31.5M $411M -$9.17M $13.05 159
2025 Q1 32M $476M -$6.9M $14.89 158
2024 Q4 31.7M $576M -$25.6M $18.16 173
2024 Q3 34.3M $461M +$2.42M $13.44 177
2024 Q2 34.5M $477M -$18.3M $13.84 161
2024 Q1 35.5M $664M -$21.9M $18.72 171
2023 Q4 36.8M $833M -$7.89M $22.64 171
2023 Q3 37.1M $919M -$5.04M $24.79 184
2023 Q2 36.6M $1.03B -$7.38M $28.08 189
2023 Q1 37.5M $836M +$27.2M $22.32 196
2022 Q4 35.9M $954M -$17.5M $26.57 230
2022 Q3 36.5M $1.03B +$20.1M $28.37 190
2022 Q2 36M $750M +$20.6M $20.83 174
2022 Q1 35.4M $767M +$23.2M $21.67 191
2021 Q4 34M $943M -$14M $27.76 181
2021 Q3 34.3M $728M +$5.85M $21.24 157
2021 Q2 34.1M $564M +$2.73M $16.51 147
2021 Q1 34.1M $425M +$11M $12.49 128
2020 Q4 33.2M $295M -$5.25M $8.87 120
2020 Q3 34M $221M -$578K $6.49 116
2020 Q2 34.2M $211M -$9.1M $6.16 122
2020 Q1 35.4M $239M -$1.89M $6.74 134
2019 Q4 35.3M $410M +$5.66M $11.62 135
2019 Q3 35M $361M +$1.99M $10.30 129
2019 Q2 35M $327M +$3.64M $9.38 119
2019 Q1 35.1M $247M +$17.6M $7.03 128
2018 Q4 32.5M $239M -$9.1M $7.33 140
2018 Q3 33.7M $294M +$4.34M $8.73 131
2018 Q2 32.7M $368M -$24.1M $11.25 136
2018 Q1 34.9M $388M +$2.69M $11.11 132
2017 Q4 34.4M $440M +$9.36M $12.76 143
2017 Q3 33.6M $478M -$14M $14.23 149
2017 Q2 34.9M $450M +$11.8M $12.91 141
2017 Q1 34M $488M +$77.5M $14.36 151
2016 Q4 32.3M $504M +$4.07M $15.61 157
2016 Q3 32.4M $382M +$5.99M $11.78 143
2016 Q2 31.8M $443M -$643K $13.92 145
2016 Q1 32.2M $374M -$4.68M $11.63 151
2015 Q4 31.8M $521M +$38.6M $16.39 164
2015 Q3 30.5M $415M +$7.76M $13.61 142
2015 Q2 30.1M $381M -$6.45M $12.68 123
2015 Q1 30.6M $363M +$9.35M $11.86 119
2014 Q4 29.8M $371M -$248K $12.48 123
2014 Q3 30M $279M +$9.55M $9.29 121
2014 Q2 29M $189M -$9.3M $6.52 115
2014 Q1 29.9M $241M +$8.72M $8.07 121